{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:29:53Z","timestamp":1789878593265,"version":"4.0.1"},"reference-count":10,"publisher":"BMJ","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40425-017-0303-9","type":"journal-article","created":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T03:26:50Z","timestamp":1511580410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma"],"prefix":"10.1136","volume":"5","author":[{"given":"Pouyan N.","family":"Changizzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Kumar R.","family":"Mukkamalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Armenio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"303_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40618-015-0301-z","volume":"38","author":"PB Araujo","year":"2015","unstructured":"Araujo PB, Coelho MCA, Arruda M, Gadelha MR, Neto LV. Ipilimumab-induced hypophysitis: review of the literature. J Endocrinol Investig. 2015;38:1159\u201366. \nhttps:\/\/doi.org\/10.1007\/s40618-015-0301-z\n\n.","journal-title":"J Endocrinol Investig"},{"key":"303_CR2","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.2337\/dc15-0889.","volume":"38","author":"M Mellati","year":"2015","unstructured":"Mellati M, Eaton KD, Brooks-Worrell BM, Hagopian WA, Martins R, Palmer JP, et al. Anti-PD-1 and anti-PDL-1 monoclonal antibodies causing type 1 diabetes. Diabetes Care. 2015;38:e137\u20138. \nhttps:\/\/doi.org\/10.2337\/dc15-0889.","journal-title":"Diabetes Care"},{"key":"303_CR3","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2337\/dc14-2349.","volume":"38","author":"J Hughes","year":"2015","unstructured":"Hughes J, Vudattu N, Sznol M, Gettinger S, Kluger H, Lupsa B, et al. Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. Diabetes Care. 2015;38:e55\u20137. \nhttps:\/\/doi.org\/10.2337\/dc14-2349.","journal-title":"Diabetes Care"},{"key":"303_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2217\/imt-2017-0020","volume":"9","author":"M Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo M, Ligeiro D, Costa L, Marques F, Trindade H, Correia JM, et al. A case of fulminant type 1 diabetes following anti-PD1 immunotherapy in a genetically susceptible patient. Immunotherapy. 2017;9:531\u20135. \nhttps:\/\/doi.org\/10.2217\/imt-2017-0020\n\n.","journal-title":"Immunotherapy"},{"key":"303_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/jdi.12531","volume":"7","author":"M Okamoto","year":"2016","unstructured":"Okamoto M, Okamoto M, Gotoh K, Masaki T, Ozeki Y, Ando H, et al. Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy. J Diabetes Investig. 2016;7:915\u20138. \nhttps:\/\/doi.org\/10.1111\/jdi.12531\n\n.","journal-title":"J Diabetes Investig"},{"key":"303_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00002371-200207000-00009","volume":"25","author":"P Fraenkel","year":"2002","unstructured":"Fraenkel P, Gollob J. Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer. J Immunother. 2002;25:373\u20138. \nhttps:\/\/doi.org\/10.1097\/00002371-200207000-00009\n\n.","journal-title":"J Immunother"},{"key":"303_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/CMR.0000000000000381","volume":"27","author":"D Sossau","year":"2017","unstructured":"Sossau D, Kofler L, Eigentler T. Type 1 diabetes mellitus caused by treatment with low-dose interferon-\u03b1 in a melanoma patient. Melanoma Res. 2017;27:516\u20138. \nhttps:\/\/doi.org\/10.1097\/CMR.0000000000000381\n\n.","journal-title":"Melanoma Res"},{"key":"303_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"MJI Ansari","year":"2003","unstructured":"Ansari MJI, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, et al. The programmed Death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003;198:63\u20139. \nhttps:\/\/doi.org\/10.1084\/jem.20022125\n\n.","journal-title":"J Exp Med"},{"key":"303_CR9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/cncr.27969","volume":"119","author":"JS Weber","year":"2013","unstructured":"Weber JS, Dummer R, De Pril V, Lebb\u00e9 C, Hodi FS. Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer. 2013;119:1675\u201382. \nhttps:\/\/doi.org\/10.1002\/cncr.27969\n\n.","journal-title":"Cancer"},{"key":"303_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0245-2","volume":"5","author":"JL Godwin","year":"2017","unstructured":"Godwin JL, Jaggi S, Sirisena I, Sharda P, Rao AD, Mehra R, et al. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer. J Immunother Cancer. 2017;5:40. \nhttps:\/\/doi.org\/10.1186\/s40425-017-0245-2\n\n.","journal-title":"J Immunother Cancer"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-017-0303-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:41:50Z","timestamp":1601055710000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-017-0303-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1186\/s40425-017-0303-9","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"97"}}